Molecular identification and anti-pathogenic activities of putative probiotic bacteria isolated from faeces of healthy elderly individuals

Microbial Ecology in Health and Disease

Volumn 16, Issue 2-3, 2004, Pages 105-112

  Likotrafiti, Eleni ^a   Manderson, Kirstie S ^a   Fava, Francesca ^a   Tuohy, Kieran M ^a   Gibson, Glenn R ^a   Rastall, Robert A ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Bifidobacterium; Campylobacter jejuni; Clostridium difficile; Elderly; Enteropathogenic Escherichia coli (EPEC); Gastrointestinal microbiota; Inhibition; Lactobacillus; Verocytotoxigenic E. coli (VTEC)

Indexed keywords

BACTERIAL DNA; DNA 16S; PROBIOTIC AGENT;

ANTIBACTERIAL ACTIVITY; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIFIDOBACTERIUM LONGUM INFANTIS; CAMPYLOBACTER JEJUNI; CLOSTRIDIUM DIFFICILE; CONFERENCE PAPER; DNA SEQUENCE; ESCHERICHIA COLI; FECES MICROFLORA; GENETIC VARIABILITY; HUMAN; LACTOBACILLUS FERMENTUM; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM BV. INFANTIS; CAMPYLOBACTER; CAMPYLOBACTER JEJUNI; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; ESCHERICHIA COLI; LACTOBACILLUS; LACTOBACILLUS FERMENTUM; MICROBIOTA;

EID: 3342984992     PISSN: 0891060X     EISSN: None     Source Type: Journal    
DOI: 10.1080/08910600410032376     Document Type: Conference Paper

References (37)

1. Blaut M, Collins MD, Welling GW, Doré J, van Loo J, de Vos W. Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br J Nutr 2002; 87(Suppl 2): S203-11.
2. McCartney AL. Application of molecular methods for studying probiotics and the gut flora. Br J Nutr 2002; 88: S29-37.
3. Finegold SM, Attebery HR, Sutter VL. Effect of diet on human fecal flora: comparison of Japanese and American diets. Am J Clin Nutr 1974; 27: 1456-69.
4. Wilson KH, Blitchington RB. Human colonic bacteria studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 1996; 62: 2273-8.
5. Suau A, Bonnet R, Sutren M, Godon J-J, Gibson GR, Collins MD, Doré J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999; 65: 4799-807.
6. Walter J, Tannock GW, Tilsala-Timisjarvi A, Rodtong S, Loach DM, Munro K, Alatossava T. Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl Environ Microbiol 2000; 66: 297-303.
7. Hammes WP, Vogel RF. The genera of lactic acid bacteria. In: Wood BJB, Holzapfel WH, eds. The Lactic Acid Bacteria, vol. 2. London: Blackie Academic and Professional, 1995: 19-54.
8. Chevalier P, Roy D, Ward P. Detection of Bifidobacterium species by enzymatic methods. J Appl Microbiol 1990; 68: 619-24.
9. Woese CR. Bacterial evolution. Microbiol Rev 1987; 51: 221-71.
10. Sullivan Å, Palmgren A-C, Nord CE. Effect of Lactobacillus paracasei on intestinal colonization of lactobacilli, bifidobacteria and Clostridium difficile in elderly persons. Anaerobe 2001; 7: 67-70.
11. Gavini F, Cayuela C, Antonie JM, Lecoq C, Lefebvre B, Membré JM, Neut C. Differences in the distribution of bifidobacterial and enterobacterial species in human faecal microflora of three different (children, adults, elderly) age groups. Microb Ecol Health Dis 2001; 13: 40-5.
12. Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 2001; 48: 198-205.
13. Saunier K, Doré J. Gastrointestinal tract and the elderly: functional foods, gut microflora and healthy ageing. Dig Liver Dis 2002; 34(Suppl 2): S19-24.
14. Tuohy KM, Likotrafiti E, Manderson K, Gibson GR, Rastall RA. Improving gut health in the elderly. In: Remacle C, Reusens B, eds. Functional Foods, Ageing and Degenerative Disease. Cambridge, UK: Woodhead, 2004 (in press).
15. Mitsuoka T. Intestinal flora and aging. Nutr Rev 1992; 50: 438-46.
16. Chateau N, Castellanos I, Deschamps AM. Distribution of pathogen inhibition in the Lactobacillus isolates of a commercial probiotic consortium. J Appl Bacteriol 1993; 74: 36-40.
17. Drago L, Gismondo MR, Lombardi A, de Haën C, Gozzini L. Inhibition of in vitro growth of enteropathogens by new Lactobacillus isolates of human intestinal origin. FEMS Microbiol Lett 1997; 153: 455-63.
18. Fang W, Shi M, Huang L, Chen J, Wang Y. Antagonism of lactic acid bacteria towards Staphylococcus aureus and Escherichia coli on agar plates and in milk. Vet Res 1996; 27: 3-12.
19. Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, Moller PL, Michaelsen KF, Paerregaard A, Sandstrom B, Tvede M, Jakobsen M. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 1999; 65: 4949-56.
20. Hudault S, Liévin V, Bernet-Camard M-F, Servin A. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 1997; 63: 513-8.
21. Harris LJ, Daechsel MA, Stiles ME, Klaenhammer TR. Antimicrobial activity of lactic acid bacteria against Listeria monocytogenes. J Food Prot 1989; 52: 384-7.
22. Koga T, Mizobe T, Takumi K. Antibacterial activity of Lactobacillus species against Vibrio species. Microbiol Res 1998; 153: 271-5.
23. Tojo M, Oikawa T, Morikawa Y. The effects of Bifidobacterium breve administration on Campylobacter enteritis. Acta Paediatr Japn 1987; 29: 160-97.
24. Coconier H-M, Liévin V, Hemery E, Servin A. Antagonistic activity against Helicobacter infection in vitro and in vivo by human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998; 64: 4573-80.
25. Greene JD, Klaenhammer TR. Factors involved in adherence of lactobacilli to human Caco-2 cells. Appl Environ Microbiol 1994; 60: 4487-94.
26. Kirjavainen PV, Ouwehand AC, Isolauri E, Salminen SJ. The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol Lett 1998; 167: 185-9.
27. Ouwehand AC, Isolauri E, Kirjavainen PV, Salminen SJ. Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiol Lett 1999; 172: 61-4.
28. Tuomola EM, Ouwehand AC, Salminen SJ. The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunol Med Microbiol 1999; 26: 137-42.
29. Forestier C, de Champs C, Vatoux C, Joly B. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res Microbiol 2001; 152: 167-73.
30. Tuohy KM, Probert HM, Smejkal CW, Gibson GR. Using probiotics and prebiotics to improve gut health. Drug Discovery Today 2003; 8: 692-700.
31. Silvi S, Verdenelli MC, Orpianesi C, Cresci A. EU project CROWNALIFE: functional foods, gut microflora and healthy ageing: isolation and identification of Lactobacillus and Bifidobacterium strains from faecal samples of elderly subjects for a possible probiotic use in functional foods. J Food Eng 2003; 56: 195-200.
32. Lawson PA, Gharbia SE, Shah HN, Clark DR. Recognition of Fusobacterium nucleatum subgroups Fn-1, Fn-2 and Fn-3 by ribosomal RNA gene restriction pattern. FEMS Microbiol Lett 1989; 65: 41-6.
33. Benno Y, Endo K, Mizutani T, Namba Y, Komori T, Mitsuoka T. Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol 1989; 55: 1100-5.
34. Hopkins MJ, Macfarlane GT. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 2002; 51: 448-54.
35. Kimura K, McCartney AL, McConnell MA, Tannock GW. Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains. Appl Environ Microbiol 1997; 63: 3394-8.
36. Fujiwara S, Hashiba H, Hirota T, Forstner JF. Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl Environ Microbiol 1997; 63: 506-12.
37. Liévin V, Peiffer I, Hudault S, Rochat F, Brassart D, Neeser J-R, Servin AL. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 2000; 47: 646-52.